{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:55:09Z","timestamp":1790186109146,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T00:00:00Z","timestamp":1774137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"DOI":"10.1186\/s13148-026-02111-2","type":"journal-article","created":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T14:55:52Z","timestamp":1774191352000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["\u03b2-Hydroxybutyrate upregulates hepatic histone \u03b2-hydroxybutyrylation modification, promotes the expression of PPAR\u03b1, and alleviates the hepatic steatosis in MASLD"],"prefix":"10.1186","volume":"18","author":[{"given":"Dongze","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jidi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulin","family":"Mou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqiu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiming","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linqiang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenlin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,22]]},"reference":[{"issue":"8","key":"2111_CR1","doi-asserted-by":"publisher","first-page":"101133","DOI":"10.1016\/j.jhepr.2024.101133","volume":"6","author":"H Wu","year":"2024","unstructured":"Wu H, Wei J, Wang S. Dietary pattern modifies the risk of MASLD through metabolomic signature. JHEP Rep. 2024;6(8):101133. https:\/\/doi.org\/10.1016\/j.jhepr.2024.101133.","journal-title":"JHEP Rep"},{"issue":"1","key":"2111_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/metabo14010012","volume":"14","author":"MM Syed-Abdul","year":"2023","unstructured":"Syed-Abdul MM. Lipid metabolism in metabolic-associated steatotic liver disease (MASLD). Metabolites. 2023;14(1):12. https:\/\/doi.org\/10.3390\/metabo14010012.","journal-title":"Metabolites"},{"issue":"1","key":"2111_CR3","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12944-024-02108-x","volume":"23","author":"Y Li","year":"2024","unstructured":"Li Y, Yang P, Ye J. Updated mechanisms of MASLD pathogenesis. Lipids Health Dis. 2024;23(1):117. https:\/\/doi.org\/10.1186\/s12944-024-02108-x.","journal-title":"Lipids Health Dis"},{"key":"2111_CR4","doi-asserted-by":"publisher","unstructured":"Qi X, Li J, Caussy C. Epidemiology, screening, and co-management of type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease. Hepatology. 2024 May;8. https:\/\/doi.org\/10.1097\/HEP.0000000000000913.","DOI":"10.1097\/HEP.0000000000000913"},{"issue":"8","key":"2111_CR5","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.tem.2024.02.007","volume":"35","author":"L Miao","year":"2024","unstructured":"Miao L, Targher G, Byrne CD. Current status and future trends of the global burden of MASLD. Trends Endocrinol Metab. 2024;35(8):697\u2013707. https:\/\/doi.org\/10.1016\/j.tem.2024.02.007.","journal-title":"Trends Endocrinol Metab"},{"issue":"10","key":"2111_CR6","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/S2468-1253(24)00193-6","volume":"9","author":"H Hagstr\u00f6m","year":"2024","unstructured":"Hagstr\u00f6m H, Shang Y, Hegmar H. Natural history and progression of metabolic dysfunction-associated steatotic liver disease. Lancet Gastroenterol Hepatol. 2024;9(10):944\u201356. https:\/\/doi.org\/10.1016\/S2468-1253(24)00193-6.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"2111_CR7","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1136\/gutjnl-2024-332398","volume":"74","author":"S Ha","year":"2024","unstructured":"Ha S, Wong VW, Zhang X, Yu J. Interplay between gut microbiome, host genetic and epigenetic modifications in MASLD and MASLD-related hepatocellular carcinoma. Gut. 2024;74(1):141\u201352. https:\/\/doi.org\/10.1136\/gutjnl-2024-332398.","journal-title":"Gut"},{"issue":"6","key":"2111_CR8","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa2309000","volume":"390","author":"SA Harrison","year":"2024","unstructured":"Harrison SA, Bedossa P, Guy CD. A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis. N Engl J Med. 2024;390(6):497\u2013509. https:\/\/doi.org\/10.1056\/NEJMoa2309000.","journal-title":"N Engl J Med"},{"issue":"11\u201312","key":"2111_CR9","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1111\/apt.18331","volume":"60","author":"PN Newsome","year":"2024","unstructured":"Newsome PN, Sanyal AJ, Engebretsen KA. Semaglutide 2.4\u00a0mg in participants with metabolic dysfunction-associated steatohepatitis: baseline characteristics and design of the phase 3 ESSENCE trial. Aliment Pharmacol Ther. 2024;60(11\u201312):1525\u201333. https:\/\/doi.org\/10.1111\/apt.18331.","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"2111_CR10","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.3390\/ijms26041778","volume":"26","author":"AG Devasia","year":"2025","unstructured":"Devasia AG, Ramasamy A, Leo CH. Current therapeutic landscape for metabolic dysfunction-associated steatohepatitis. Int J Mol Sci. 2025;26(4):1778. https:\/\/doi.org\/10.3390\/ijms26041778.","journal-title":"Int J Mol Sci"},{"issue":"22","key":"2111_CR11","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.3390\/cells13221893","volume":"13","author":"D Stols-Gon\u00e7alves","year":"2024","unstructured":"Stols-Gon\u00e7alves D, Meijnikman AS, Trist\u00e3o LS. Metabolic dysfunction-associated steatotic liver disease and alcohol-associated liver disease: liver DNA methylation analysis-A systematic review. Cells. 2024;13(22):1893. https:\/\/doi.org\/10.3390\/cells13221893.","journal-title":"Cells"},{"issue":"6","key":"2111_CR12","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.jhep.2024.01.029","volume":"80","author":"Z Zou","year":"2024","unstructured":"Zou Z, Liu X, Yu J. se in mice.Nuclear miR-204-3p mitigates metabolic dysfunction-associated steatotic liver disea. J Hepatol. 2024;80(6):834\u201345. https:\/\/doi.org\/10.1016\/j.jhep.2024.01.029.","journal-title":"J Hepatol"},{"issue":"10","key":"2111_CR13","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1002\/ijc.70047","volume":"157","author":"C Aiello","year":"2025","unstructured":"Aiello C, Felli E, Musarra T. Rewriting the MASLD-associated hepatocellular carcinoma script: targeting epigenetics and metabolism. Int J Cancer. 2025;157(10):1991\u20132003. https:\/\/doi.org\/10.1002\/ijc.70047.","journal-title":"Int J Cancer"},{"issue":"3","key":"2111_CR14","doi-asserted-by":"publisher","first-page":"253","DOI":"10.7570\/jomes24041","volume":"34","author":"I Zahoor","year":"2025","unstructured":"Zahoor I, Mir GJ, Lone NA. Crosstalk between epigenetics and autophagy in metabolic dysfunction-associated steatotic liver disease. J Obes Metab Syndr. 2025;34(3):253\u201367. https:\/\/doi.org\/10.7570\/jomes24041. Epub 2025 Jun 16.","journal-title":"J Obes Metab Syndr"},{"issue":"1","key":"2111_CR15","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s41392-024-01918-w","volume":"9","author":"W Yao","year":"2024","unstructured":"Yao W, Hu X, Wang X. Crossing epigenetic frontiers: the intersection of novel histone modifications and diseases. Signal Transduct Target Ther. 2024;9(1):232. https:\/\/doi.org\/10.1038\/s41392-024-01918-w.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2111_CR16","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41392-023-01333-7","volume":"8","author":"YL Wu","year":"2023","unstructured":"Wu YL, Lin ZJ, Li CC. Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study. Signal Transduct Target Ther. 2023;8(1):98. https:\/\/doi.org\/10.1038\/s41392-023-01333-7.","journal-title":"Signal Transduct Target Ther"},{"key":"2111_CR17","doi-asserted-by":"publisher","first-page":"113984","DOI":"10.1016\/j.biopha.2022.113984","volume":"156","author":"D Li","year":"2022","unstructured":"Li D, Zhang L, He Y. Novel histone post-translational modifications in diabetes and complications of diabetes: the underlying mechanisms and implications. Biomed Pharmacother. 2022;156:113984. https:\/\/doi.org\/10.1016\/j.biopha.2022.113984.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"2111_CR18","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13148-025-01814-2","volume":"17","author":"D Li","year":"2025","unstructured":"Li D, Zhang L, Gong Q. The role of myocardial energy metabolism perturbations in diabetic cardiomyopathy: from the perspective of novel protein post-translational modifications. Clin Epigenetics. 2025;17(1):15. https:\/\/doi.org\/10.1186\/s13148-025-01814-2.","journal-title":"Clin Epigenetics"},{"key":"2111_CR19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cbpa.2018.02.004","volume":"45","author":"S Nadal","year":"2018","unstructured":"Nadal S, Raj R, Mohammed S. Synthetic post-translational modification of histones. Curr Opin Chem Biol. 2018;45:35\u201347. https:\/\/doi.org\/10.1016\/j.cbpa.2018.02.004.","journal-title":"Curr Opin Chem Biol"},{"key":"2111_CR20","doi-asserted-by":"publisher","unstructured":"Jin S, Chen P, Yang J. Phocaeicola vulgatus alleviates diet-induced metabolic dysfunction-associated steatotic liver disease progression by downregulating histone acetylation level via 3-HPAA. Gut Microbes. 2024;16(1):2309683. https:\/\/doi.org\/10.1080\/19490976.2024.2309683.","DOI":"10.1080\/19490976.2024.2309683"},{"issue":"1","key":"2111_CR21","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13578-025-01411-z","volume":"15","author":"Y Min","year":"2025","unstructured":"Min Y, Zhang Y, Ji Y. Post-translational modifications in the pathophysiological process of metabolic dysfunction-associated steatotic liver disease. Cell Biosci. 2025;15(1):79. https:\/\/doi.org\/10.1186\/s13578-025-01411-z.","journal-title":"Cell Biosci"},{"issue":"5","key":"2111_CR22","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41580-021-00441-y","volume":"23","author":"M Shvedunova","year":"2022","unstructured":"Shvedunova M, Akhtar A. Modulation of cellular processes by histone and non-histone protein acetylation. Nat Rev Mol Cell Biol. 2022;23(5):329\u201349. https:\/\/doi.org\/10.1038\/s41580-021-00441-y.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"9","key":"2111_CR23","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41576-022-00468-7","volume":"23","author":"G Mill\u00e1n-Zambrano","year":"2022","unstructured":"Mill\u00e1n-Zambrano G, Burton A, Bannister AJ. Histone post-translational modifications\u2013cause and consequence of genome function. Nat Rev Genet. 2022;23(9):563\u201380. https:\/\/doi.org\/10.1038\/s41576-022-00468-7.","journal-title":"Nat Rev Genet"},{"key":"2111_CR24","doi-asserted-by":"publisher","first-page":"105502","DOI":"10.1016\/j.ebiom.2024.105502","volume":"111","author":"C Bao","year":"2025","unstructured":"Bao C, Ma Q, Ying X. Histone lactylation in macrophage biology and disease: from plasticity regulation to therapeutic implications. EBioMedicine. 2025;111:105502. https:\/\/doi.org\/10.1016\/j.ebiom.2024.105502.","journal-title":"EBioMedicine"},{"issue":"1","key":"2111_CR25","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41420-024-01830-w","volume":"10","author":"JY Xie","year":"2024","unstructured":"Xie JY, Ju J, Zhou P. The mechanisms, regulations, and functions of histone lysine crotonylation. Cell Death Discov. 2024;10(1):66. https:\/\/doi.org\/10.1038\/s41420-024-01830-w.","journal-title":"Cell Death Discov"},{"issue":"10","key":"2111_CR26","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.3390\/genes12101596","volume":"12","author":"V Cavalieri","year":"2021","unstructured":"Cavalieri V. The expanding constellation of histone post-translational modifications in the epigenetic landscape. Genes (Basel). 2021;12(10):1596. https:\/\/doi.org\/10.3390\/genes12101596.","journal-title":"Genes (Basel)"},{"key":"2111_CR27","doi-asserted-by":"publisher","first-page":"981285","DOI":"10.3389\/fimmu.2022.981285","volume":"13","author":"T Zhou","year":"2022","unstructured":"Zhou T, Cheng X, He Y, Xie Y, Xu F, Xu Y, Huang W. Function and mechanism of histone \u03b2-hydroxybutyrylation in health and disease. Front Immunol. 2022;13:981285. https:\/\/doi.org\/10.3389\/fimmu.2022.981285. PMID: 36172354; PMCID: PMC9511043.","journal-title":"Front Immunol"},{"issue":"12","key":"2111_CR28","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1038\/s42255-023-00935-3","volume":"5","author":"AB Nelson","year":"2023","unstructured":"Nelson AB, Queathem ED, Puchalska P. Metabolic messengers: ketone bodies. Nat Metab. 2023;5(12):2062\u201374. https:\/\/doi.org\/10.1038\/s42255-023-00935-3.","journal-title":"Nat Metab"},{"key":"2111_CR29","doi-asserted-by":"publisher","first-page":"1518687","DOI":"10.3389\/fimmu.2025.1518687","volume":"16","author":"A Provera","year":"2025","unstructured":"Provera A, Ramavath NN, Gadipudi LL. Vegetal oil-based ketogenic diet improves inflammation and fibrosis in experimental metabolic dysfunction-associated steatohepatitis. Front Immunol. 2025;16:1518687. https:\/\/doi.org\/10.3389\/fimmu.2025.1518687.","journal-title":"Front Immunol"},{"issue":"7","key":"2111_CR30","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1161\/CIRCRESAHA.123.321872","volume":"132","author":"TR Matsuura","year":"2023","unstructured":"Matsuura TR, Puchalska P, Crawford PA. Ketones and the heart: metabolic principles and therapeutic implications. Circ Res. 2023;132(7):882\u201398. https:\/\/doi.org\/10.1161\/CIRCRESAHA.123.321872.","journal-title":"Circ Res"},{"issue":"12","key":"2111_CR31","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1038\/s44161-024-00565-2","volume":"3","author":"T Du","year":"2024","unstructured":"Du T, Han Y, Han H. The tRNA methyltransferase Mettl1 governs ketogenesis through translational regulation and drives metabolic reprogramming in cardiomyocyte maturation. Nat Cardiovasc Res. 2024;3(12):1438\u201353. https:\/\/doi.org\/10.1038\/s44161-024-00565-2.","journal-title":"Nat Cardiovasc Res"},{"issue":"27","key":"2111_CR32","doi-asserted-by":"publisher","first-page":"13533","DOI":"10.1073\/pnas.1820282116","volume":"116","author":"T Miyauchi","year":"2019","unstructured":"Miyauchi T, Uchida Y, Kadono K. Up-regulation of FOXO1 and reduced inflammation by \u03b2-hydroxybutyric acid are essential diet restriction benefits against liver injury. Proc Natl Acad Sci U S A. 2019;116(27):13533\u201342. https:\/\/doi.org\/10.1073\/pnas.1820282116.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2111_CR33","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.cell.2024.10.032","volume":"188","author":"MD Moya-Garzon","year":"2025","unstructured":"Moya-Garzon MD, Wang M, Li VL. A \u03b2-hydroxybutyrate shunt pathway generates anti-obesity ketone metabolites. Cell. 2025;188(1):175\u2013e18620. https:\/\/doi.org\/10.1016\/j.cell.2024.10.032.","journal-title":"Cell"},{"issue":"5","key":"2111_CR34","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1210\/er.2018-00064","volume":"39","author":"N Bougarne","year":"2018","unstructured":"Bougarne N, Weyers B, Desmet SJ. Molecular actions of PPAR\u03b1 in lipid metabolism and inflammation. Endocr Rev. 2018;39(5):760\u2013802. https:\/\/doi.org\/10.1210\/er.2018-00064.","journal-title":"Endocr Rev"},{"key":"2111_CR35","doi-asserted-by":"publisher","first-page":"101117","DOI":"10.1016\/j.plipres.2021.101117","volume":"84","author":"M Sz\u00e1nt\u00f3","year":"2021","unstructured":"Sz\u00e1nt\u00f3 M, Gupte R, Kraus WL. PARPs in lipid metabolism and related diseases. Prog Lipid Res. 2021;84:101117. https:\/\/doi.org\/10.1016\/j.plipres.2021.101117.","journal-title":"Prog Lipid Res"},{"key":"2111_CR36","doi-asserted-by":"publisher","first-page":"106786","DOI":"10.1016\/j.phrs.2023.106786","volume":"192","author":"YY Qiu","year":"2023","unstructured":"Qiu YY, Zhang J, Zeng FY. Roles of the peroxisome proliferator-activated receptors (PPARs) in the pathogenesis of nonalcoholic fatty liver disease (NAFLD). Pharmacol Res. 2023;192:106786. https:\/\/doi.org\/10.1016\/j.phrs.2023.106786.","journal-title":"Pharmacol Res"},{"key":"2111_CR37","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.ejmech.2019.01.067","volume":"166","author":"AZ Mirza","year":"2019","unstructured":"Mirza AZ, Althagafi II, Shamshad H. Role of PPAR receptor in different diseases and their ligands: physiological importance and clinical implications. Eur J Med Chem. 2019;166:502\u201313. https:\/\/doi.org\/10.1016\/j.ejmech.2019.01.067.","journal-title":"Eur J Med Chem"},{"issue":"2","key":"2111_CR38","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.molcel.2016.03.036","volume":"62","author":"Z Xie","year":"2016","unstructured":"Xie Z, Zhang D, Chung D. Metabolic regulation of gene expression by histone lysine \u03b2-hydroxybutyrylation. Mol Cell. 2016;62(2):194\u2013206. https:\/\/doi.org\/10.1016\/j.molcel.2016.03.036.","journal-title":"Mol Cell"},{"issue":"33","key":"2111_CR39","doi-asserted-by":"publisher","first-page":"eadv8448","DOI":"10.1126\/sciadv.adv8448","volume":"11","author":"S Wang","year":"2025","unstructured":"Wang S, Niu Z, Zhang Y. ACSS2 coupled with KAT7 regulates histone \u03b2-hydroxybutyrylation to enhance transcription. Sci Adv. 2025;11(33):eadv8448. https:\/\/doi.org\/10.1126\/sciadv.adv8448.","journal-title":"Sci Adv"},{"issue":"7","key":"2111_CR40","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/j.molcel.2025.02.022","volume":"85","author":"M Tang","year":"2025","unstructured":"Tang M, Tu Y, Gong Y. \u03b2-hydroxybutyrate facilitates mitochondrial-derived vesicle biogenesis and improves mitochondrial functions. Mol Cell. 2025;85(7):1395\u2013e14105. https:\/\/doi.org\/10.1016\/j.molcel.2025.02.022.","journal-title":"Mol Cell"},{"issue":"4","key":"2111_CR41","doi-asserted-by":"publisher","first-page":"E493","DOI":"10.1152\/ajpendo.00336.2023","volume":"326","author":"MP Moore","year":"2024","unstructured":"Moore MP, Shryack G, Alessi I. Relationship between serum \u03b2-hydroxybutyrate and hepatic fatty acid oxidation in individuals with obesity and NAFLD. Am J Physiol Endocrinol Metab. 2024;326(4):E493\u2013502. https:\/\/doi.org\/10.1152\/ajpendo.00336.2023.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2111_CR42","doi-asserted-by":"publisher","first-page":"117070","DOI":"10.1016\/j.bcp.2025.117070","volume":"239","author":"X Ma","year":"2025","unstructured":"Ma X, Wang Z, Gao H. \u03b2-Hydroxybutyrate dehydrogenase 1: a promising therapeutic target for diverse diseases. Biochem Pharmacol. 2025;239:117070. https:\/\/doi.org\/10.1016\/j.bcp.2025.117070.","journal-title":"Biochem Pharmacol"},{"issue":"12","key":"2111_CR43","doi-asserted-by":"publisher","first-page":"e191021","DOI":"10.1172\/JCI191021","volume":"135","author":"ED Queathem","year":"2025","unstructured":"Queathem ED, Stagg DB, Nelson AB. Ketogenesis mitigates metabolic dysfunction-associated steatotic liver disease through mechanisms that extend beyond fat oxidation. J Clin Invest. 2025;135(12):e191021. https:\/\/doi.org\/10.1172\/JCI191021.","journal-title":"J Clin Invest"},{"issue":"1","key":"2111_CR44","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s00018-025-05819-1","volume":"82","author":"J Cai","year":"2025","unstructured":"Cai J, Li W, Wu C. \u03b2-Hydroxybutyrate enhances malate dehydrogenase 2 \u03b2-hydroxybutyrylation to alleviate hepatic steatosis in MASLD. Cell Mol Life Sci. 2025;82(1):361. https:\/\/doi.org\/10.1007\/s00018-025-05819-1.","journal-title":"Cell Mol Life Sci"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-026-02111-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-026-02111-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-026-02111-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:29:24Z","timestamp":1777508964000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13148-026-02111-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,22]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2111"],"URL":"https:\/\/doi.org\/10.1186\/s13148-026-02111-2","relation":{},"ISSN":["1868-7083"],"issn-type":[{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,22]]},"assertion":[{"value":"22 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This experiment received approval from the Experimental Animal Ethics Committee of the Affiliated Hospital of Southwest Medical University (No. KY2022142).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors approved the final manuscript for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"77"}}